Hatfield, Stephen M.

Immunological mechanisms of the antitumor effects of supplemental oxygenation

Hatfield, S. M., Kjaergaard, J., Lukashev, D., Schreiber, T. H., Belikoff, B., Abbott, R., Sethumadhavan, S., Philbrook, P., Ko, K., Cannici, R., et al. (2015) · Science Translational Medicine

Adenosine and Purinergic SignalingCancer Immunotherapy and Biomarkers

Cited by 600

Hostile, Hypoxia–A2-Adenosinergic Tumor Biology as the Next Barrier to Overcome for Tumor Immunologists

Sitkovsky, M. V., Hatfield, S., Abbott, R., Belikoff, B., Lukashev, D., & Ohta, A. (2014) · Cancer Immunology Research

Adenosine and Purinergic SignalingCancer Immunotherapy and Biomarkers

Cited by 215

Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection

Hatfield, S. M., Kjaergaard, J., Lukashev, D., Belikoff, B., Schreiber, T. H., Sethumadhavan, S., Abbott, R., Philbrook, P., Thayer, M., Shujia, D., et al. (2014) · Journal of Molecular Medicine

Cancer, Hypoxia, and MetabolismAdenosine and Purinergic Signaling

Cited by 211

A2A Adenosine Receptor Gene Deletion or Synthetic A2A Antagonist Liberate Tumor-Reactive CD8+ T Cells from Tumor-Induced Immunosuppression

Kjaergaard, J., Hatfield, S., Jones, G., Ohta, A., & Sitkovsky, M. (2018) · The Journal of Immunology

Adenosine and Purinergic SignalingCancer Immunotherapy and Biomarkers

Cited by 132

Hypoxia and hypoxia-inducible factor (HIF) downregulate antigen-presenting MHC class I molecules limiting tumor cell recognition by T cells

Sethumadhavan, S., Silva, M., Philbrook, P., Nguyen, T., Hatfield, S. M., Ohta, A., & Sitkovsky, M. V. (2017) · PLOS ONE

Immunotherapy and Immune ResponsesCancer, Hypoxia, and Metabolism

Cited by 119

Antihypoxic oxygenation agents with respiratory hyperoxia to improve cancer immunotherapy

Hatfield, S. M., & Sitkovsky, M. V. (2020) · Journal of Clinical Investigation

Cancer, Hypoxia, and MetabolismAdenosine and Purinergic Signaling

Cited by 73

Oxygenation to improve cancer vaccines, adoptive cell transfer and blockade of immunological negative regulators

Hatfield, S. M., & Sitkovsky, M. (2015) · OncoImmunology

Adenosine and Purinergic SignalingCancer Immunotherapy and Biomarkers

Cited by 31